Valuation: FDC Limited

Market Cap 57.63B 607M 545M 503M 456M 852M 863M 6.03B 2.39B 30.21B 2.28B 2.23B 95.79B P/E 2025
24.1x
P/E 2026 18.6x
Enterprise Value 52.57B 553M 497M 459M 416M 777M 787M 5.5B 2.18B 27.55B 2.08B 2.03B 87.37B EV / Sales 2025
2.8x
EV / Sales 2026 2.18x
Free-Float
30.06%
Yield 2025
1.27%
Yield 2026 1.56%
1 day+6.41%
1 week+10.91%
Current month+10.86%
1 month+9.86%
3 months-7.63%
6 months+3.23%
Current year-11.02%
1 week 330.5
Extreme 330.5
385
1 month 321.5
Extreme 321.5
385
Current year 314.75
Extreme 314.75
442
1 year 314.75
Extreme 314.75
473.3
3 years 314.75
Extreme 314.75
659
5 years 229.15
Extreme 229.15
659
10 years 148.2
Extreme 148.2
659
Manager TitleAgeSince
Chief Executive Officer 90 19/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 24/10/2025
Director TitleAgeSince
Director/Board Member 48 01/01/2002
Director/Board Member 63 30/09/1993
Chairman 90 01/04/2026
Change 5-day change 1-year change 3-year change Capi.($)
+6.41%+10.91%-12.86%+3.23% 607M
-0.28%-0.14%+55.12%+128.82% 1,143B
-0.57%+3.61%+41.21%+84.57% 647B
-0.78%-0.93%+25.59%+106.14% 506B
-0.49%+0.97%+51.59%+64.03% 384B
-0.47%-4.37%+61.16%+37.93% 350B
+0.47%+1.64%+30.43%+52.38% 293B
-0.44%+0.92%+2.61%+24.58% 265B
-0.73%+2.05%+53.85%+71.25% 242B
-0.65%+1.64%+32.05%+107.62% 197B
Average +0.21%+1.06%+34.08%+68.06% 402.81B
Weighted average by Cap. -0.46%+0.71%+42.90%+87.85%

Financials

2025 2026
Net sales 21.08B 222M 199M 184M 167M 312M 316M 2.21B 876M 11.05B 833M 815M 35.04B 21.71B 229M 205M 189M 172M 321M 325M 2.27B 902M 11.38B 858M 840M 36.08B
Net income 2.67B 28.09M 25.21M 23.28M 21.11M 39.45M 39.93M 279M 111M 1.4B 105M 103M 4.43B 2.81B 29.63M 26.59M 24.55M 22.27M 41.61M 42.13M 294M 117M 1.48B 111M 109M 4.68B
Net Debt -5.15B -54.21M -48.66M -44.93M -40.74M -76.15M -77.08M -539M -214M -2.7B -204M -199M -8.56B -5.06B -53.28M -47.82M -44.15M -40.04M -74.83M -75.75M -529M -210M -2.65B -200M -196M -8.41B
Projected Income Statement - Annual - FDC Limited
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
7,076
Date Price Change Volume
28/10/26 INR 376.65 +6.41% 67,947
27/10/26 INR 353.95 +2.36% 118,092
26/10/26 INR 345.80 +2.05% 12,514
23/10/26 INR 338.85 -0.40% 5,406
22/10/26 INR 340.20 +0.18% 7,071
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B